Cerebral Acquires Leading ADHD Behavioral App, Inflow, Expanding Access to Continuous Care

Audio By Carbonatix

NEW YORK--(BUSINESS WIRE)--Mar 24, 2026--

Cerebral, a prominent provider of integrated mental health care, today announced its acquisition of Inflow, a personalized ADHD digital therapeutic app, reinforcing Cerebral’s mission of delivering accessible, quality behavioral healthcare.

The addition of Inflow allows Cerebral to provide additional continuous support options to its patients with ADHD beyond their appointments, by combining clinical care with personalized engagement tools and helping them build long-term, measurable skills. The integrated offering seeks to improve patients’ outcomes over time, lowering the total cost of care.

“High quality ADHD treatments are a significant and growing area of need, underscoring the importance of scalable, validated tools that offer support both during and in between sessions,” said Dr. Carl Marci, Chief Medical Officer of Cerebral. “With Inflow, we can further serve our patients by strengthening everyday coping skills and fostering long-term, lifelong resilience.”

Adult ADHD prevalence has been on the rise in recent years, from ~4.4% historically to ~6.0% in 2023 ( CDC ). Approximately 36.5% of adults diagnosed with ADHD in the U.S. receive no formal treatment ( CDC ), suggesting a high degree of unmet clinical need.

Inflow is grounded in Cognitive Behavioral Therapy (CBT) principles and offers its subscribers short, science-based lessons and daily skills-based modules that help them build awareness, change habits, and manage their ADHD day-to-day. The acquisition expands Cerebral’s treatment portfolio to include enhanced ADHD-specific programs and digital tools enabling more personalized pathways and continuous care tailored to each individual’s needs.

“Cerebral shares our vision for delivering evidenced-based support that builds skills and long term success, and we couldn’t be more excited to enter this next chapter in the delivery of continuous care. This partnership allows us to leverage our personalized approach, while benefiting from Cerebral’s clinical rigor, proven Resilience Methodology, and scale,” said Levi Epstein, CEO and Co-Founder of Inflow.

With Inflow, Cerebral now offers a more comprehensive continuum of care for individuals with ADHD—further supporting patients from diagnosis through ongoing treatment (including therapy and medication management options), and between-session skills training and support. Both companies will continue to operate as separate platforms. Cerebral clinicians will now be more readily accessible for any member of Inflow seeking therapy with quick turn around time for an appointment.

About Cerebral

Cerebral sets a new standard of high quality integrated mental healthcare for over 100 million commercially insured people by seamlessly providing therapy and psychiatry in one place, along with medication delivery. Our diverse, national network of clinicians train and certify in the Resilience Methodology, which takes great care to focus on client first quality clinical outcomes, delivering actionable plans for personalized care, and equipping clients with skill building strategies to successfully cope with future challenges. Learn more at www.cerebral.com.

About Inflow

Inflow is a digital self-care app designed to support individuals with ADHD related challenges in their day-to-day lives. Grounded in cognitive behavioral therapy (CBT), Inflow delivers science-based interactive micro-lessons, practical tools and guided support that help individuals build skills, develop healthier habits and better manage ADHD-related challenges over time. Inflow has been evaluated in peer-reviewed studies including a randomized control trial and has been used by hundreds of thousands of people globally. In an 8-week randomized controlled trial, Inflow users showed significant improvements in ADHD symptoms and ADHD-related quality of life. Higher engagement with Inflow’s exercises was associated with greater self-reported improvements in attention, and users rated the app highly for ease of use and satisfaction. The platform can be used on its own or alongside other forms of care, providing ongoing support before, during and after clinical treatment. Learn more at www.getinflow.io.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260324103905/en/

For more information or to schedule an interview, please [email protected].

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: TECHNOLOGY HEALTH GENERAL HEALTH NEUROLOGY MENTAL HEALTH HEALTH TECHNOLOGY OTHER SCIENCE MEDICAL DEVICES APPS/APPLICATIONS SOFTWARE SCIENCE

SOURCE: Cerebral

Copyright Business Wire 2026.

PUB: 03/24/2026 08:00 AM/DISC: 03/24/2026 08:01 AM

http://www.businesswire.com/news/home/20260324103905/en